Through multiple mechanisms, HNSCC can reduce MHC-I antigen presentation, diminish CD8+ T cell activity, decrease interferon-gamma (IFN-γ) secretion, and ultimately become resistant to immunotherapy.170. The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.